Currently, depression is increasingly considered as one of the triggers in the development of metabolic syndrome. This is due to the fact that affective disorders contribute to the formation of risk factors, which, according to the recommendations of the All-Russian Scientific Society of Cardiology for the diagnosis and treatment of metabolic syndrome, lead to the development of metabolic disorders. The main risk factors are: overeating, physical inactivity and hypertension. And indeed, in a state of depression, the physical activity decreases, appetite increases, and hyperreactivity of the sympathetic nervous system (sympathicotonic syndrome) is a trigger factor for increased blood pressure. The fact that the association between depression and metabolic syndrome is a "two–way street" is confirmed by the results of a prospective cohort study of Whitehall II in 2009, which was performed by T.N. Akbaralya et al. Epidemiological studies are currently represented by data from samples of patients with metabolic syndrome quite large volumes. The most representative are the studies published in 2004 by L.S. Kinder et al. The authors of the work, which analyzed the material collected over 6 years, indicate that in a group of 3003 examined people aged 17 to 39 years, the proportion of people with metabolic syndrome is 2 times higher in cases where there is a history of an episode of depressive disorder. L. Witterberg et al. proposed the concept of "low melatonin syndrome" in patients with depressive disorders. According to this model, low melatonin levels may be the main reason for a decrease in the levels of norepinephrine and serotonin in the brain and indirectly affect the dysfunction of the hypothalamic-pituitary system, which in turn can be used as a marker of predisposition to the development of depressive disorders. At the same time, there are works discussing the role of melatonin in the development of dysmetabolism. In recent years, there has been an increase in patients with metabolic syndrome, which is a significant medical problem. The severity of clinical manifestations of metabolic syndrome affects the quality of life of patients, while physical and mental health indicators decrease. Obesity leads to anxiety disorders, neurosis-like conditions and depression, which contributes to the deterioration of the underlying disease. The available clinical and experimental data convincingly show the presence of multiple pathophysiological links that explain the high probability of the formation of metabolic syndrome in people with anxiety and depressive disorders.
| Mualliflar | TURAEV Tolib Makhmudjonovich, KUCHIMOVA Charos Azamatovna |
|---|---|
| Jurnal | Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali |
| Nashr sanasi | 2024-06-15 |
| Jild | 9 |
| Son | 2 |
| Til | Ingliz |
тревога, депрессия, метаболический синдром, ожирение, особенности лечения., vahima, depressiya, metabolik sindrom, semirish, davolash xususiyatlari
The coronavirus disease (COVID-19) pandemic has attracted greater attention than ever before to the problems of immunopathology of human diseases, many of which are reflected in the study of neurodegenerative diseases…
For scientific research, we conducted tests for herpes infection in patients with chronic dorsopathy, who were treated in the neurology department of the city medical association. It should be noted that chronic…
A total of 46 patients with cognitive disorders (their age was 65-85 years old) participated in our observation in two identical groups: 23 patients in the main group and 23 patients in the second group. We used the…
The constant increase in the incidence of brucellosis is becoming a global problem in the world. Under our control, 35 patients with peripheral nervous system damage accompanied by pain in chronic brucellosis made up…
The authors studied the morphological changes in the gastric mucosa in 232 patients with H. pylori-associated gastric diseases. The results of the study showed that the intensity of morphological changes in the stomach…
The article analyzes a literature review of publications that discuss the positive and negative points of view of the use of stem cells in brain therapy for neurodegenerative diseases. The ability of a stem cell to…
Primary myelofibrosis (PM) is rare disease with newly incidence about 1 : 100 000 inhabitants per year. The names for primary myelofi brosis used before were agnogenic myeloid metaplasia, chronic idiopathic metaplasia…
Objective is to develop methods for early diagnosis, prognosis of cardiorenal syndrome in children with acute nephritic syndrome. Materials and Methods: The study was conducted on 105 children hospitalized with acute…
Analysis of modern literature indicates the relevance of the problem being studied and indicates that antitumor drugs, widely used in the treatment of patients with malignant neoplasms, can have undesirable side effects…
The incidence of complications after acute respiratory viral infections - pathologies of the bronchopulmonary system. The incidence of the bronchopulmonary system remains one of the most pressing pathologies among the…
Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar